Multiple sclerosis (MS) is a disease of the central nervous system characterized by
inflammation, demyelination, and neuronal damage. Environmental and genetic factors are …

Epstein-Barr virus (EBV) is a ubiquitous human virus which infects almost all humans during
their lifetime and following the acute phase, persists for the remainder of the life of the …

T-cell immunotherapy that takes advantage of Epstein-Barr virus (EBV)–stimulated immunity
has the potential to fill an important niche in targeted therapy for EBV-related cancers. To …

The recent emergence of a causal link between Epstein-Barr virus (EBV) and multiple
sclerosis has generated considerable interest in the development of an effective vaccine …

We present the results of a multicenter clinical trial using Epstein-Barr virus (EBV)–specific
cytotoxic T lymphocytes (CTLs) generated from EBV-seropositive blood donors to treat …

Immunocompromised individuals are at high risk for life-threatening diseases, especially
those caused by cytomegalovirus (CMV), Epstein-Barr virus (EBV) and adenovirus …

Impaired immunity in patients with late-stage cancer is not limited to antitumor responses, as
demonstrated by poor vaccination protection and high susceptibility to infection,–. This has …

BACKGROUND. Increasing evidence indicates a role for EBV in the pathogenesis of
multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the CNS …

Conventional treatment for nasopharyngeal carcinoma (NPC) frequently fails and is
accompanied by severe long-term side effects. Since virtually all undifferentiated NPCs are …

EBV-encoded microRNAs (miRNAs) have been identified and their functions are being
studied. The expression pattern of these miRNAs in clinical samples of EBV-associated non …